- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0029060

Aptivos Medicira LLP
About Aptivos Medicira LLP
Data last updated:
Aptivos Medicira LLP is a limited liability partnership (LLP) based in Thane, Maharashtra, India. It operates in the chemicals and chemical products segment of the chemicals sector. It was incorporated on 02 April 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAG-1164. Its GSTIN is 27ABFFA4975N1ZU (Maharashtra).
The LLP has a total obligation of contribution of βΉ1 Lakh. It is led by designated partners Sandhya Chandrakant Bodke and Vikrant Chandrakant Bodke.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at 302 Prathmesh Hills Dhokali Naka Kolshet Road, Thane, Maharashtra, India β 400607.
Aptivos Medicira LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0029060).
Company details
Recognitions & Rankings of Aptivos Medicira
Contact details
Aptivos Medicira LLP's registered office is in Thane, Maharashtra.
- Registered Address302 Prathmesh Hills Dhokali Naka Kolshet Road, Thane, Maharashtra, India β 400607
- IndustryChemicals, Chemicals and Chemical Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aptivos Medicira LLP
FY 2024 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | |||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | |||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Aptivos Medicira LLP, buy the company report.
Designated partners of Aptivos Medicira LLP
Aptivos Medicira has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandhya Chandrakant Bodke | Designated Partner | 10 Jan 2021 | 5 Years 9 Months | Current |
| Vikrant Chandrakant Bodke Also directs: RX Nutra India Private Limited, Meditica 360 Private Limited | Designated Partner | 02 Apr 2016 | 10 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Aptivos Medicira LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aptivos Medicira LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aptivos Medicira has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABFFA4975N1ZU | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aptivos Medicira LLP, buy the company report.
Recent activity
Aptivos Medicira LLP has 3 designated partner changes on record since 2016: 2 appointments and 1 cessation. The latest: Sandhya Chandrakant Bodke was appointed as Designated Partner on 10 Jan 2021.
Frequently asked questions
Aptivos Medicira is an active limited liability partnership based in Thane, Maharashtra, India. The LLP works in chemicals and chemical products, within the chemicals industry. It was incorporated on 02 April 2016 (10+ years old) and is registered under LLPIN AAG-1164.
Aptivos Medicira has 2 current designated partners:
- Sandhya Chandrakant Bodke - Designated Partner
- Vikrant Chandrakant Bodke - Designated Partner
The latest financial statements of Aptivos Medicira on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Aptivos Medicira is 27ABFFA4975N1ZU, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Aptivos Medicira is AAG-1164. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Aptivos Medicira was incorporated on 02 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Sandhya Chandrakant Bodke was appointed as Designated Partner on 10 Jan 2021. Kajal Ashish Thakker ceased to be Designated Partner on 01 Jan 2020. Vikrant Chandrakant Bodke was appointed as Designated Partner on 02 Apr 2016.
Yes, Aptivos Medicira is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0029060).
The registered office of Aptivos Medicira is at 302 Prathmesh Hills Dhokali Naka Kolshet Road, Thane, Maharashtra, India β 400607.
Aptivos Medicira operates in the chemicals industry, in the chemicals and chemical products segment.